Laith Al‐Rabadi

739 total citations
23 papers, 242 citations indexed

About

Laith Al‐Rabadi is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Laith Al‐Rabadi has authored 23 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 6 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Laith Al‐Rabadi's work include Renal Diseases and Glomerulopathies (12 papers), Autoimmune Bullous Skin Diseases (3 papers) and Renal and related cancers (3 papers). Laith Al‐Rabadi is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Autoimmune Bullous Skin Diseases (3 papers) and Renal and related cancers (3 papers). Laith Al‐Rabadi collaborates with scholars based in United States, Jordan and Italy. Laith Al‐Rabadi's co-authors include Tiffany Caza, Laurence H. Beck, Jean Francis, András Perl, Sowmya Shivanna, Elazer R. Edelman, Michael P. Pollastri, Janice Weinberg, Anqi Zhang and Moshe Shashar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Laith Al‐Rabadi

20 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laith Al‐Rabadi United States 8 129 75 41 37 31 23 242
Víctor Barrientos Chile 5 80 0.6× 85 1.1× 22 0.5× 52 1.4× 27 0.9× 11 366
Roser Guiteras Spain 9 120 0.9× 102 1.4× 43 1.0× 94 2.5× 22 0.7× 12 312
Scott Van Why United States 9 84 0.7× 109 1.5× 44 1.1× 22 0.6× 58 1.9× 9 339
Lidia Hyla‐Klekot Poland 10 62 0.5× 62 0.8× 38 0.9× 15 0.4× 46 1.5× 40 286
Nayra Pérez‐Delgado Spain 11 259 2.0× 84 1.1× 33 0.8× 27 0.7× 39 1.3× 20 381
Matthias Wuttke Germany 10 155 1.2× 132 1.8× 51 1.2× 16 0.4× 36 1.2× 24 357
Scott W. Rose United States 5 41 0.3× 247 3.3× 26 0.6× 75 2.0× 38 1.2× 7 371
Tomomi Endo Japan 7 155 1.2× 63 0.8× 89 2.2× 38 1.0× 41 1.3× 22 261
Ewelina Łukaszyk Poland 7 46 0.4× 24 0.3× 42 1.0× 18 0.5× 22 0.7× 9 207
Elena Rodríguez‐Sánchez Spain 11 147 1.1× 81 1.1× 35 0.9× 19 0.5× 28 0.9× 32 350

Countries citing papers authored by Laith Al‐Rabadi

Since Specialization
Citations

This map shows the geographic impact of Laith Al‐Rabadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laith Al‐Rabadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laith Al‐Rabadi more than expected).

Fields of papers citing papers by Laith Al‐Rabadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laith Al‐Rabadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laith Al‐Rabadi. The network helps show where Laith Al‐Rabadi may publish in the future.

Co-authorship network of co-authors of Laith Al‐Rabadi

This figure shows the co-authorship network connecting the top 25 collaborators of Laith Al‐Rabadi. A scholar is included among the top collaborators of Laith Al‐Rabadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laith Al‐Rabadi. Laith Al‐Rabadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caza, Tiffany, Samar Hassen, Laith Al‐Rabadi, et al.. (2025). Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathy. Kidney International. 108(3). 427–432.
2.
Al‐Rabadi, Laith, Aaron J. Storey, Christopher P. Larsen, et al.. (2024). De novo Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1. Kidney International Reports. 10(1). 247–251. 3 indexed citations
3.
Gregory, Martin C., et al.. (2024). Ocular Coherence Tomography Unveils Alport Syndrome: A Critical Tool in Detecting Collagen IV Nephropathies. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
4.
Clair, Gérémy, Paolo Cravedi, Andrea Angeletti, et al.. (2024). The spatially resolved transcriptome signatures of glomeruli in chronic kidney disease. JCI Insight. 9(6). 7 indexed citations
5.
Al‐Rabadi, Laith, et al.. (2024). Coexistence of Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease: A Case Report. Journal of the American Society of Nephrology. 35(10S).
6.
Caza, Tiffany, et al.. (2022). Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis. Translational research. 245. 55–81. 30 indexed citations
7.
Al‐Rabadi, Laith & Laurence H. Beck. (2022). Neuronal Proteins as Antigenic Targets in Membranous Nephropathy. ˜The œNephron journals/Nephron journals. 147(8). 451–457. 7 indexed citations
8.
Huang, Zhimin, Simeng Liu, Anna Tang, et al.. (2021). Key role for EphB2 receptor in kidney fibrosis. Clinical Science. 135(17). 2127–2142. 16 indexed citations
9.
Simeone, Christopher A., et al.. (2021). Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease. American Journal of Nephrology. 52(3). 239–249. 7 indexed citations
10.
Al‐Rabadi, Laith, et al.. (2021). IgA Nephropathy Post COVID-19 Infection. Journal of the American Society of Nephrology. 32(10S). 769–770.
11.
Caza, Tiffany, Laith Al‐Rabadi, & Laurence H. Beck. (2021). How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Frontiers in Immunology. 12. 800242–800242. 16 indexed citations
12.
Caza, Tiffany, Samar Hassen, Michael Kuperman, et al.. (2020). NCAM1 Is an Autoantigen in Membranous Lupus Nephritis. Journal of the American Society of Nephrology. 31(10S). 27–27. 4 indexed citations
13.
Singhania, Namrata, Girish Singhania, & Laith Al‐Rabadi. (2020). Acquired Reactive Perforating Collagenosis. Clinical and Experimental Nephrology. 24(11). 1086–1087. 3 indexed citations
14.
Singhania, Namrata, et al.. (2020). Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal. SHILAP Revista de lepidopterología. 8(4). 722–724. 6 indexed citations
15.
Al‐Rabadi, Laith, Tiffany Caza, Aylin R. Rodan, et al.. (2020). High Temperature Recombinant Protein A1 (HTRA1): A Novel Antigen in Membranous Nephropathy. Journal of the American Society of Nephrology. 31(10S). 25–26. 4 indexed citations
16.
Khalighi, Mazdak A., et al.. (2018). Staphylococcal Infection–Related Glomerulonephritis With Cryoglobulinemic Features. Kidney International Reports. 3(5). 1128–1134. 11 indexed citations
17.
Al‐Rabadi, Laith, Karen Quillen, Moshe Shashar, et al.. (2017). Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy. Kidney International Reports. 3(2). 476–481. 2 indexed citations
18.
Shivanna, Sowmya, Kumaran Kolandaivelu, Moshe Shashar, et al.. (2015). The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia. Journal of the American Society of Nephrology. 27(1). 189–201. 87 indexed citations
19.
Al‐Rabadi, Laith, Jean Francis, Joel Henderson, & Sandeep Ghai. (2015). Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts. Clinical Kidney Journal. 8(6). 722–728. 9 indexed citations
20.
Al‐Rabadi, Laith, Rivka Ayalon, Ramon Bonegio, et al.. (2015). Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. American Journal of Kidney Diseases. 67(5). 775–778. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Víctor Barrientos Breakdown of academic impact, for papers by Roser Guiteras Breakdown of academic impact, for papers by Scott Van Why Breakdown of academic impact, for papers by Lidia Hyla‐Klekot Breakdown of academic impact, for papers by Nayra Pérez‐Delgado Breakdown of academic impact, for papers by Matthias Wuttke Breakdown of academic impact, for papers by Scott W. Rose Breakdown of academic impact, for papers by Tomomi Endo Breakdown of academic impact, for papers by Ewelina Łukaszyk Breakdown of academic impact, for papers by Elena Rodríguez‐Sánchez
Rankless by CCL
2026